Skip to search formSkip to main contentSkip to account menu
Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial.
TLDR
Examination of clinical sleep disorder diagnoses in 257 patients found substantial site-related differences in diagnostic patterns, confirming the importance of psychiatric and behavioral factors in clinicians' assessments of insomnia patients across all three diagnostic systems.
View on PubMed
Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial.
TLDR
Site-related variability indicates a need for greater standardization in the application of sleep disorder diagnostic criteria, and the distribution of diagnoses highlights the importance of psychiatric and behavioral factors in the assessment of insomnia.
View on PubMed
Next-day memory impairment with triazolam use
View on Elsevier
Effects of lovastatin and pravastatin on sleep efficiency and sleep stages
TLDR
Lovastatin's sleep disturbing effects with continued administration are attributed to its high degree of lipophilicity in contrast with the hydrophilicity of pravastatin.
View on Wiley
Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders.
TLDR
The results support the face validity of clinical factors used by sleep specialists to distinguish primary insomnia from insomnia related to mental disorders and suggest the need for studies on the validity of negative conditioning and sleep hygiene in the etiology of primary insomnia.
View on PubMed
Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines
TLDR
It is indicated that even under conditions of brief, intermittent use and withdrawal, triazolam and, to a lesser degree, temazepam produce rebound insomnia after abrupt withdrawal, thereby predisposing to drug‐taking behavior and increasing the potential for drug dependence.
View on Wiley
Comparison of short and long half‐life benzodiazepine hypnotics: Triazolam and quazepam
TLDR
The 0.25 mg dose of triazolam, which is being prescribed increasingly, has a profile of side effects that is similar to that of the 0.5 mg dose, and is associated with sleep and mood disturbances whereas quazepam exerted carryover effectiveness.
View on Wiley
Effects of diagnosis on treatment recommendations in chronic insomnia--a report from the APA/NIMH DSM-IV field trial.
TLDR
Differences in treatment recommendations support the distinction between different DSM-IV and ICSD diagnoses, although they do not provide formal validation, and site-related differences suggest a lack of consensus in how these disorders are conceptualized and treated.
View on PubMed
Effects of nadolol on blood pressure, sleep efficiency, and sleep stages
TLDR
The effects of nadolol (20 and 80 mg) on blood pressure and sleep parameters were assessed in six patients with mild hypertension and neither dose had a disrupting effect on sleep, whereas the 80 mg dose improved sleep efficiency and also had a rapid eye movement‐enhancing effect.
View on Wiley
Uvulopalatopharyngoplasty as a treatment of obstructive sleep apnea precipitated by uvular prolapse.
TLDR
The experience illustrates that the surgical approach to obstructive sleep apnea is dependent on a thorough diagnostic evaluation that includes a sleep history, head and neck examination, hypnopolygraphic recording and, if indicated, nocturnal fiberoptic endoscopy.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License